MI
GILD icon

Motiv8 Investments’s Gilead Sciences GILD Stock Holding History

Motiv8 Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.51M Sell
12,273
-1,935
-14% -$235K 0.82% 48
2025
Q3 		$1.58M Buy
14,208
+1,017
+8% +$116K 0.84% 53
2025
Q2 		$1.46M Buy
13,191
+1,412
+12% +$150K 0.89% 40
2025
Q1 		$1.32M Sell
11,779
-378
-3% -$39K 0.88% 34
2024
Q4 		$1.12M Buy
+12,157
New +$1.09M 0.79% 49

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Motiv8 Investments's GILD Position: Q4 2025 in Review

Motiv8 Investments reduced its Gilead Sciences (GILD) stake by 14% in Q4 2025, selling an estimated $235K and leaving 12,273 shares worth $1.51M. The position accounts for 0.82% of the portfolio, ranked #48.

Motiv8 Investments first reported a position in GILD in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.58M in Q3 2025. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Motiv8 Investments held 12,273 shares of Gilead Sciences worth $1.51M as of Q4 2025.
  • Motiv8 Investments sold 1,935 Gilead Sciences shares in Q4 2025, an estimated $235K.
  • Gilead Sciences made up 0.82% of Motiv8 Investments's portfolio in Q4 2025, its #48 holding.
  • Motiv8 Investments first reported a position in Gilead Sciences in Q4 2024 and has held it in 5 quarters since.
  • Motiv8 Investments's Gilead Sciences position peaked at $1.58M in Q3 2025.
  • 2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.